![Pulse Biosciences Inc](/common/images/company/N_PLSE.png)
Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfun... Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems. Show more
The start of the Fed taper and the gradual end of the cheap money era have indeed left deep scars on the emerging market nations. In fact, the outflow of hot money from these developing countries...
Recent market gyrations resulting from worries over the end of cheap dollars and a slew of downbeat economic data in the U.S. have shaken investor confidence in the U.S. equity markets. This has...
As the taper begins to ravage international markets, investors in the ETF world are starting to see the impact of currencies on foreign holdings. Many currencies are slumping against the U.S...
DJ CFA SOURCE: SEC 13F-HR FILER: Caxton Associates LP QUARTER ENDED: 09/30/2013 SEC RECEIVED: 11/14/2013 Up to 200 of the largest purchases of Caxton Associates LP are listed below, ordered by...
DJ CFA SOURCE: SEC 13F-HR FILER: Caxton Associates LP QUARTER ENDED: 09/30/2013 SEC RECEIVED: 11/14/2013 The following sets forth up to 200 of the largest holdings of Caxton Associates LP as of...
August was a rough month for global equities as concerns over higher rates and geopolitical worries kept stocks in check across the board. In fact, during August, SPY lost a bit over 4% in the...
Emerging economies have been performing quite poorly due to feeble demand, lower commodity prices, struggling currencies, increasing chances of tapering and further dollar...
News on the job front this morning leaned towards the modestly disappointing side. Softness in job growth is now apparent. That being said, adding +119K jobs is in line with a muddle...
Investors finally saw a decisive down day in the markets, ending the relatively bullish trend that many had been seeing for the past few weeks. This abrupt shift wasn’t the result of any...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.19 | -12.7696793003 | 17.15 | 19.49 | 14.07 | 226687 | 16.83146041 | CS |
4 | 3.58 | 31.4586994728 | 11.38 | 20.4382 | 11.13 | 334161 | 16.3288517 | CS |
12 | 7.58 | 102.7100271 | 7.38 | 20.4382 | 6.66 | 277216 | 13.39834854 | CS |
26 | 5.86 | 64.3956043956 | 9.1 | 20.4382 | 6.595 | 215919 | 11.36923644 | CS |
52 | 6.26 | 71.9540229885 | 8.7 | 20.4382 | 3.78 | 227974 | 9.50054387 | CS |
156 | -5.41 | -26.558664703 | 20.37 | 29.16 | 1.18 | 167270 | 7.33877028 | CS |
260 | 1.6 | 11.9760479042 | 13.36 | 45.82 | 1.18 | 139067 | 10.00501512 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.